Comparison of Efficacy of Intravenous Diltiazem and Esmolol in Terminating Supraventricular Tachycardia

Journal of Association of Physicians of India

Volumn 47, Issue 10, 1999, Pages 969-972

  Gupta, A ^a   Naik, A ^a   Vora, A ^a   Lokhandwala, Y ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ESMOLOL; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPANOLAMINES; PROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 0033205321     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Waxman MB, Sharma AB, Cameron DS, Huerta F, Wald RW. Reflex mechanisms responsible for early spontaneous termination of paroxysmal supraventricular tachycardia. Am J Cardiol 1982; 49 : 259.
2. Zipes DP, Jalife J. Cardiac electrophysiology. From cell to bedside. Second edition. WB Saunders Company, Philadelphia. 1995; 646-7.
3. DiMarco JP, Miles WM, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia : Dose ranging and comparison with verapamil. Ann Intern Med 1990; 113 : 104.
4. Sung RJ, Elser B, McAllister RG. Intravenous verapamil for termination of reentrant supraventricular tachycardia. Ann Intern Med 1980; 93 : 682.
5. Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia. Indian Heart J 1994; 46 : 141-4.
6. Smetnev AS, Titov VN, Shevchenko NM, Gurevich EM. Use of digoxin in patients with paroxysmal supraventricular tachycardia. Kardiologiia 1989; 29 : 61-4.
7. Wellens HJ, Duren DR, Liem DL, Lie KI. Effects of digitalis in patients with paroxysmal atrio-ventricular nodal tachycardia. Circulation 1975; 52 : 779-88.
8. Gmeiner R, Ng CK. Metoprolol in the treatment and prophylaxis of paroxysmal re-entrant supraventricular tachycardia. J Cardiovasc Pharmacol 1982; 4 : 5-13.
9. Rowland E, McKenna WJ, Gulker H, Krikler DM. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia. Circ Res 1983; 52 (suppl I) : 163-8.
10. Betriu A, Crannan BR, Bourassa MG, et al. Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias. Circulation 1983; 67 : 88-94.
11. Philippon F, Plumb VJ, Kay GN. Differential effect of esmolol on the fast and slow AV nodal pathways in-patients with AV nodal re-entrant tachycardia. J Cardiovasc Electrophysiol 1994; 5 : 810-7.
12. Das G, Ferris J. Esmolol in the treatment of supraventricular tachyarrhythmias, Can J Cardiol 1988; 4 : 177-80.
13. Huycke EC, Sung RJ, Dias VC, Milstein S, Hariman RJ, Platia EV. Intravenous diltiazem for termination of reentrant supraventricular tachycardia : A placebo - controlled, randomized, double blind, multicentric study. J Am Coll Cardiol 1989; 13 : 538-44.
14. Joel G Hardman, Alfred Goodman Gilnian, Lee E Limbard Goodman, Gilman's The pharmacological basis of therapeutics. Ninth edition. The McGraw Hill Companies. 1996; 860-1.
15. Opei LH, Frishman WH, Thadani U. Drugs for the heart. Fourth edition. 1995; 26.
16. Kawai C, Konisii T, Matsuyama E, Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes : experimental and clinical studies. Circulation 1981; 63 : 1035-42.
17. Klein GJ, Gulamhusein S, Prytowsky EN, et al. Comparison of the electrophysiologic effects of intravenous and oral verapamil in-patients with paroxysmal supraventricular tachycardia. Am J Cardiol 1982; 49 : 117-24.
18. Krikler DM, Spurrell RAJ. Verapamil in treatment of paroxysmal supraventricular tachycardia. Postgrad Med J 1974; 50 : 447-53.
19. Greenspan AM, Speilman SR, Horowitz LM, Senior S, Steck J. electrophysiology of esmolol. Am J Cardiol 1985; 56 : 19F-26F.
20. Lowenthal DJ, Porter RS, Saris SD, Bies CM, Slegowski MB. Clinical pharmacology, pharmacodynamics and interaction of esmolol. Am J Cardiol 1985; 56 : 14F-18F.